CD19-targeted CAR T cells

· Shanghai Ming Ju Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for CD19-targeted CAR T cells, covering 2023-11-24 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: CAR T Cells in the Treatment of Refractory and Relapsed CD19+ B Cell Neoplasms [Phase 1]